•Morpheus Research alleges MakeMyTrip continues anti-competitive price parity practices despite a 2022 penalty from the Competition Commission of India (CCI).
•The report alleges accounting irregularities and the use of misleading financial metrics by the company.
•The report claims there is an undisclosed CCI investigation due in early 2026.
•Gan & Lee Pharmaceuticals announced that its once-weekly insulin GZR4 injection met primary endpoints in two pivotal Phase 3 clinical trials, SUPER-1 and SUPER-2.
•The SUPER-1 and SUPER-2 trials are pivotal for evaluating the efficacy and safety of the investigative basal insulin GZR4.
•The company's shares are traded on the Shanghai Stock Exchange under the ticker 603087.
•Vital Farms faces a class action lawsuit alleging it misled investors about the risks and impact of delays in its new Enterprise Resource Planning (ERP) system.
•The lawsuit, filed by Bragar Eagel & Squire, claims the company downplayed issues, leading to missed earnings and investor losses.
•The lawsuit covers investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026.
•Alphabet (GOOGL) shares rose approximately 4.83% to trade around $287 during Tuesday's session.
•The stock climb is attributed to Wall Street's reaction to a 'nine-minute warning' from Google regarding Bitcoin, likely linked to quantum computing risks.
•This price action follows previous reports warning that advanced quantum machines could crack Bitcoin's encryption within 10 years.